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Background: The COVID-19 pandemic catalyzed the adoption of home telemonitoring to cope with social distancing challenges.
Recent research on home telemonitoring demonstrated benefits concerning the capacity, patient empowerment, and treatment
commitment of health care systems. Moreover, for some diseases, it revealed significant improvement in clinical outcomes.
Nevertheless, when policy makers and practitioners decide whether to scale-up a technology-based health intervention from a
research study to mainstream care delivery, it is essential to assess other relevant domains, such as its feasibility to be expanded
under real-world conditions. Therefore, scalability assessment is critical, and it encompasses multiple domains to ensure
population-wide access to the benefits of the growing technological potential for home telemonitoring services in health care.
Objective: This systematic review aims to identify the domains and methods used in peer-reviewed research studies that assess
the scalability of home telemonitoring–based interventions under real-world conditions.
Methods: The authors followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines
and used multiple databases (PubMed, Scopus, Web of Science, and EconLit). An integrative synthesis of the eligible studies
was conducted to better explore each intervention and summarize relevant information concerning the target audience, intervention
duration and setting, and type of technology. Each study design was classified based on the strength of its evidence. Lastly, the
authors conducted narrative and thematic analyses to identify the domains, and qualitative and quantitative methods used to
support scalability assessment.
Results: This review evaluated 13 articles focusing on the potential of scaling up a home telemonitoring intervention. Most of
the studies considered the following domains relevant for scalability assessment: problem (13), intervention (12), effectiveness
(13), and costs and benefits (10). Although cost-effectiveness was the most common evaluation method, the authors identified
seven additional cost analysis methods to evaluate the costs. Other domains were less considered, such as the sociopolitical context
(2), workforce (4), and technological infrastructure (3). Researchers used different methodological approaches to assess the
effectiveness, costs and benefits, fidelity, and acceptability.
Conclusions: This systematic review suggests that when assessing scalability, researchers select the domains specifically related
to the intervention while ignoring others related to the contextual, technological, and environmental factors, which are also
relevant. Additionally, studies report using different methods to evaluate the same domain, which makes comparison difficult.
Future work should address research on the minimum required domains to assess the scalability of remote telemonitoring services
and suggest methods that allow comparison among studies to provide better support to decision makers during large-scale
implementation.
(JMIR Mhealth Uhealth 2021;9(8):e29381) doi: 10.2196/29381
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Introduction
The Universal Health Coverage commitment aligned with the
emergence of COVID-19 reinforced the value of telemedicine
services and elected these services crucial to coping with the
pandemic’s challenges in the health care sector. Since the
pandemic reached the western countries, home telemonitoring
offered an alternative to control the health status of infected
nonsevere patients at their homes to avoid unnecessary visits
to the hospital [1].
During the early part of 2020, from a social perspective, the
fast-track solution to prevent the spread of COVID-19 focused
on social distancing [2]. Governments forced people to stay at
home, canceled mass gatherings, imposed teleworking, and
closed all educational institutions [3]. From a health care
perspective, governments took some extreme measures to
increase the capacity to cope with the virus, namely reduction
or deferral of nonurgent care and hands-on visits, and
postponement of nonurgent surgeries [4]. These measures
exposed high-risk groups, such as the elderly at home, people
at long-term care facilities, patients with chronic conditions,
and hidden diseases [5]. Inevitably, physicians started
following-up with their patients through video calls and remote
monitoring to continue treatment and avoid long-term
complications [6]. In parallel, health care providers launched
new telehealth services to assist patients in their homes [7].
Policy makers and practitioners did not have enough information
to decide which pilot intervention they should disseminate into
real-world settings, considering different financial
reimbursement strategies, health care system organizations, and
workforce acceptance levels [8].
With technological progression and decreasing equipment costs,
remote patient monitoring emerged as a telemedicine
application. It comprises interactive and noninteractive
technologies to support health care and monitor patients’health
status in their homes [9].
Home telemonitoring is one type of remote patient monitoring,
which has shown and is showing potential to improve clinical
and patient-reported outcomes and ensure cost reductions for
health care practices [10]. In this work, the authors consider the
definition given by Paré and colleagues [11] for home
telemonitoring. A service based on home telemonitoring consists
of health care professionals monitoring the patient's health status
at a distance. Patients or caregivers transmit their health-related
data to a responsible health care professional through
information and telecommunication technologies. Research on
home telemonitoring showed benefits concerning health care
systems’ capacity constraints [12], patient empowerment, and
treatment commitment [13]. It revealed significant improvement
in clinical outcomes even in some diseases [11]. Despite the
considerable investment in accelerating health information
technology [14], there is not enough information on determining
whether home telemonitoring is appropriate and feasible for
implementation in a real-world context [15]. Scaling up a health
intervention requires wise and efficient spending of resources
[16]. Therefore, it is crucial to assess the suitability of scaling
up home telemonitoring interventions with proven efficacy to
provide answers to the following two questions [17]: Does it
work in practice? Is it worth it?
To answer these questions and decide which technology-based
health intervention can be scaled up for mainstream care
delivery, one must assess its scalability (ie, the ability to be
expanded to real-world conditions without compromising on
effectiveness and access to the eligible population) [18].
Most of the studies focus only on assessing the effectiveness
and costs of a health intervention. Nevertheless, these are two
of many considerations to address when evaluating the potential
of scaling up an intervention [19]. Other domains such as the
feasibility and adaptability of the health intervention and the
political or strategic contexts are rarely analyzed. As emphasized
by Milat and his colleagues [15] in their recently proposed
Intervention Scalability Assessment Tool (ISAT), assessing a
health intervention’s scalability involves considering multiple
domains, such as the political and strategic contexts, workforce,
and infrastructure, among others.
There is a need to conduct evidence-based studies that assess
pilot interventions’potential to achieve population-wide benefits
[20]. Scalability studies that also consider the intervention’s
suitability to the socioeconomic context in question are
important to estimate the success of deploying these
interventions in different contexts [15].
Owing to the lack of research on scalability analysis, in this
paper, the authors present a systematic review, based on Milat
and colleagues’ domains [15], to identify and characterize
methods used to assess the potential to scale-up home
telemonitoring interventions in the context of a growing
telehealth service in the industry. This study focuses on
peer-reviewed studies conducted to evaluate the scalability of
follow-up interventions based on home telemonitoring. The
authors aim to provide a comprehensive overview of these
studies concerning the domains and methods used and identify
gaps for future research to address when evaluating the potential
to implement or scale-up home telemonitoring interventions.
As the authors are not aware of other systematic reviews
focusing on this aspect, they believe that this review will
enlighten researchers, practitioners, and policy makers regarding
the most used strategies to assess the scalability of home
telemonitoring interventions.
Methods
The search strategy followed the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analysis) guidelines
to conduct the review [21]. The population, intervention,
comparison, outcome (PICO) framework [21] allowed the
identification of key concepts such as “Home Telemonitoring,”
“Follow-up,” “Scalability,” and “Assessment” to formulate a
well-focused question and facilitate the literature search. To
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optimize the search through effective queries, the authors used
PubMed’s Medical Subject Headings (MeSH) to identify
indexed terms [22]. This step was fundamental as this review
emerges from the combination of research fields with different
terms for the same concept. Textbox 1 presents the rationale
used to build the final query used in each database.
Textbox 1. Queries used to search each database.
1. (((Telemonitoring) OR (Home remote monitoring)) AND (Mobile Health OR health OR mHealth OR eHealth OR Telehealth OR Telemedicine))
OR (Telehomecare)
2. (Scalability) OR (Feasibility) OR (Scaling up OR scale up OR upscale OR up-scale OR scale-up) OR ((Deployment OR Implementation OR
Application) OR (Broad-scale OR Wide-scale OR Widespread OR Mainstream)) OR (((Efficienc*) AND (Program OR Intervention)) OR Economic*
Viability)
3. (Follow-up Care* OR Follow Up Care* OR Care*) OR (Case Management OR Patient Care Planning)
4. ((Appraisal* OR Evaluation* OR Assessment* OR Appropriateness) AND ((Impact) OR (Cost-Effective* OR Qualitative OR Quantitative OR
Index* OR Methodolog*) OR (Clinical Trial* AND (Pragmatic OR Naturalistic Randomized OR Practical OR Real World)) OR (Sustainability) OR
(Profitability) OR (Risk*)))
5. #1 AND #2 AND #3 AND #4
Figure 1 illustrates the search performed in PubMed, Scopus,
Web of Science, and EconLit covering studies from 2000 to
2020 (Figure 1 - Set #1). The authors chose to explore EconLit
owing to the economic evaluation required to assess a health
care intervention’s scalability. The authors selected full-text
and peer-reviewed papers written in English (Figure 1 - Set #2).
After removing the duplicates and references without abstracts
(Figure 1 - Set #3), two authors independently scanned the titles
and abstracts identified in the literature search and applied the
selection criteria presented in Textbox 2 (Figure 1 - Set #4).
To guarantee that the article’s topic aligned with the research
question, the same authors scanned the 49 full-text articles,
which reduced the number of studies considered for review to
13 (Set #5).
The authors analyzed 13 full-text articles, corresponding to 13
studies, in detail and registered all the observations in a literature
matrix [23]. First, to better explore each intervention and
summarize relevant, well-specified, and secure data, the authors
conducted an integrative synthesis. The main variables were
the country of origin, publication year, sample size, setting,
duration of follow-up, comparator arms, type of technology,
and study outcomes [24].
Second, the authors assessed the strength of each eligible study’s
evidence according to the 9-level classification system proposed
by Jovell and Navarro-Rubio [25].
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Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram showing the included studies.
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Textbox 2. Eligibility criteria for screening titles, abstracts, and full-text papers.
Inclusion criteria
• Health interventions shown to be efficacious on a small scale or under controlled conditions
• Assessment of the health intervention’s ability to be expanded to real-world conditions to reach a more significant proportion of the eligible
population while retaining effectiveness.
• Studies assessing at least one domain of scalability through the evaluation of feasibility, acceptability, costs, sustainability or, adaptability (ie,
to suit the needs of the context in which it is to be scaled up)
• Described methods to assess the scalability of a health intervention
Exclusion criteria
• Telemonitoring involving invasive medical devices
• Studies that use telemonitoring “not involving the patients, their relatives, or informal caregivers, their relatives, or informal caregivers
• Studies that described the concept of scalability without providing an assessment method
• Studies just focusing on describing disease risk patterns or intervention efficacy testing
• Study protocols or medical testing procedures for potential scalability assessment and possible scale-up
• Statistical or conceptual modeling without a real-world study
• Facilitators and barriers to scale-up within specific interventions or general experiences of scale-up that did not provide a scalability assessment
method
• Studies recommending an assessment method (of feasibility or acceptability or costs or sustainability or adaptability), but that did not assess the
potential to scale-up a telemonitoring-based health intervention
Finally, they conducted narrative and thematic analyses to
identify themes and patterns in the eligible articles and outline
the findings under specific headings [24] to better examine how
each study assessed the potential of scaling up an intervention.
When disagreements occurred, the authors reached a consensus
via discussion. One author extracted data from the studies and
completed quotes, and the second author validated the data
according to the definition of each category. The authors
conducted this analysis based on the work undertaken by Milat
and colleagues [18] in the development of a tool to perform
systematic assessments of the suitability of health interventions
for scale-up (ISAT). ISAT comprises three parts: setting the
scene, planning the intervention implementation, and
summarizing the scalability assessment. The first two parts
made it possible to classify each study according to the stage
of scale-up, context, and focus area. Moreover, Milat and
colleagues’domains enabled the authors to identify the methods
and instruments used by the researchers to assess the
intervention’s scalability [18].
The research conducted for each domain assessed in the eligible
papers was classified as qualitative or quantitative. The research
was classified as qualitative if it was based on the description
of experiences, emotions, behaviors, events, or actions [26] and
quantitative when the respective authors used numerical data
to measure, categorize, or identify patterns, relationships, or
generalizations through statistical analysis [26].
Results
Country of Origin and Year of Publication
From 2009 to 2020, the authors analyzed 13 studies in 7
countries, which focused on the potential to scale-up home
telemonitoring health care interventions; however, more than
half (n=7) were published between 2018 and 2020. Most of the
articles (n=8) were from Canada and the United States, whereas
the rest were from 5 European countries—Denmark (n=1), Italy
(n=1), Lithuania (n=1), Netherlands (n=1), and Spain (n=1).
Population and Home Telemonitoring Intervention
Assessment
Target Condition or Disease
The studies addressed either chronic or acute conditions, with
a higher number of studies addressing only chronic conditions
(n=8). The full spectrum of chronic conditions covered were
cardiovascular diseases (n=4), chronic obstructive pulmonary
diseases (n=2), cerebrovascular diseases (n=1), chronic
obstructive sleep apnea (n=1), cystic fibrosis (n=1), and diabetes
mellitus (gestational [n=1] and type 1 and 2 [n=1]). Further,
one study only characterized the patients’ condition as chronic
or acute, and the remaining studies addressed multiple conditions
(eg, surgical patients, cardiovascular and pulmonary diseases,
diabetes mellitus).
Duration and Setting of Home Telemonitoring
Intervention
Home telemonitoring was integrated into a follow-up service
in the 13 studies and required a responsible health care
professional (or a team) to manage the patient’s care. The
minimum duration of the follow-up was 3 consecutive nights
(sleep apnea [27]). However, the 1-year (n=4) and 6-month
(n=4) follow-up interventions were the most implemented. In
particular, authors reporting the secondary prevention of
cerebrovascular disease [28] defined the intervention according
to recommended monitoring protocols, assuming a 20-year time
horizon for the modeling strategy. Moreover, 10 studies had 2
dedicated teams for executing the intervention; one was
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responsible for the patient’s holistic care management and the
other for telecare management. In two studies, the conventional
care team was accountable for usual care and telecare
management, and in the other, there was no traditional care
team.
Types of Technologies
The technologies used in the studies ranged from a kit with just
one regular telephone (1) to an integrated communication and
data collection system with mobile devices (5). Moreover, six
studies conducted home telemonitoring interventions with an
integrated clinical data system, remote monitoring digital




The average total sample size of the studies was approximately
436 (maximum: 3086, minimum: 34), with an average treatment
and control group size of 260.
To better understand the type of research conducted, it is
essential to highlight that 6 out of the 13 studies were
experimental. Therefore, the authors of these studies allocated
participants to different treatment groups. As the other 7 studies
were observational, there was no allocation of the participants.
Most of the studies (n=10) were comparative studies (control
group) with conventional care services, and the other 3 were
single-arm studies.
Study Design Classification
According to the 9-level classification system proposed by
Jovell and Navarro-Rubio [25], the studies conducted by Padwal
and colleagues [28], and Vestergaard and colleagues [29] were
classified as “very good,” as they conducted randomized
controlled trials with large samples. The studies by Lugo and
colleagues [27], and Paré and colleagues [30] were classified
as “good” as these studies were randomized controlled trials
with small samples. Furthermore, the studies of Ware and
colleagues [31], as well as Zaliūnas and colleagues [32], were
classified as “poor” because they consisted of noncontrolled
clinical series or descriptive studies. The other 7 were classified
as fair and included nonrandomized controlled prospective
studies (n=3), cohort studies (n=3), and case-control studies
(n=1).
Scalability Assessment
Table 1 displays the scalability assessment domains for each
study.
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Table 1. Scalability assessment domains for each study.



















































































The authors classified eight studies as being in the pre–scale-up
stage because their descriptions consisted of steps or activities
conducted before scaling up the evidence-based home
telemonitoring intervention. Two studies described steps or
actions involved in the dissemination of the intervention. The
authors classified the other three studies as being in the
implementation stage because their descriptions indicated using
or integrating the evidence-based intervention within a setting.
Domains Considered for Scale-Up
Although all the studies described the problem under
intervention and the target population, one study [36] did not
provide details concerning the proposed home telemonitoring
intervention to address the issue. All studies referred to the level
of evidence available to support the proposed intervention’s
scale-up, either by referring to their work or other scientific
literature., Three studies did not consider the known costs and
benefits of delivering the intervention [31,32,39], and three
more did not consider the strategic/political/environmental
contexts that influence the scaling up of the intervention
[27,35,36].
Domains Considered for Implementation Planning
Seven studies considered intervention changes when assessing
fidelity, and nine studies assessed the level of acceptability
perceived by the program deliverers or recipients of the
intervention. Further, 9 studies referred to the definition of the
intervention settings and the workforce required to scale-up,
and 10 described the necessary infrastructure.
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All the studies accounted for the sustainability of the home
telemonitoring service by either referring to the long-term
outcomes of the scale-up or the medium- and long-term
sustainability of the intervention following scale-up.
Methods for Scalability Assessment
This section explains the research foci and methods used by the
eligible studies in each domain of scalability assessment. When
describing the problems, interventions, and contexts of their
studies, all the researchers adopted qualitative research methods,
as Table 2 shows. The definitions of the domains and research
foci are given in Multimedia Appendix 1. We have included
six publications [40-45] in this appendix.
Table 2. Qualitative studies on scalability assessment considering the problem, intervention, and context domains for scale-up.
ReferenceStudies, nData analysis techniqueData collection techniqueResearch typeResearch focusDomain
[27-39,46-50]13Narrative summaryDocument analysisQualitativeProblem descriptionProblem
[27-35,37-39]12Narrative summaryDocument analysisQualitativeIntervention descrip-
tion
Intervention
[28-34,37-39]10Narrative summaryDocument analysisQualitativeContext descriptionContext
All the studies adopted quantitative research methods to assess
clinical outcomes namely surveys or questionnaires (n=10),
published databases (n=2), and observations (n=1) (Table 3).
To assess humanistic and satisfaction outcomes, the researchers
chose surveys or questionnaires; however, for assessing for
usage outcomes, they either conducted observations (n=9) or
used published databases (n=3). As for validated instruments,
only one was used in one study [27] to assess clinical outcomes,
namely the Epworth Sleepiness Scale (ESS) [51]. For assessing
humanistic outcomes, three validated questionnaires were used:
EuroQol 5-Dimensions 5-Levels (EQ-5D-5L) [52] in the
contexts of heart failure [29] and obstructive sleep apnea [27];
Quebec Sleep Questionnaire (QSQ) [53] for obstructive sleep
apnea; and Chronic obstructive pulmonary disease Assessment
Test (CAT) [54] for chronic obstructive pulmonary disease [39].
In the context of ischemic heart disease [32], two more validated
questionnaires were used: Patient Satisfaction Questionnaire
Form III (PSQIII) [55] and Thought Control Questionnaire
(TCQ) [56].
Table 3. Quantitative research studies involving data analyses using descriptive and inferential statistics for scalability assessment considering the
effectiveness domain for scale-up.
ReferenceStudies, nResearch focus and data collection technique
Clinical outcome assessment
[28,36,38]3Observation; published databases
[29-35,37,39]9Nonvalidated surveys or questionnaires
[27]1Validated surveys or questionnaires
Humanistic outcome assessment
[32-34]3Nonvalidated surveys or questionnaires
[27,29,39]3Validated surveys or questionnaires
Satisfaction assessment
[27,29,30,33,34,37,39]7Nonvalidated surveys or questionnaires
[32]1Validated surveys or questionnaires
For the domains of fidelity and acceptability, quantitative
research methods involving observations were more
predominantly used as the main data collection methods, as
shown in Tables 4 and 5. Contrarily, for analyzing infrastructure,
setting, and workforce, most of the studies chose qualitative
techniques (n=8).
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Table 4. Studies on scalability assessment concerning the reach and acceptability domain for implementation planning involving data analyses using
descriptive and inferential statistics.





[31]1Nonvalidated surveys or question-
naires
Quantitative
[32]1Validated surveys or questionnairesQuantitative
Penetration assessment
[31,37]2ObservationQuantitative
Table 5. Research focus and methods found in the studies for scalability assessment concerning the fidelity and adaptability domain for implementation
planning.












When conducting economic evaluation (Table 6), the authors
found 7 different types of techniques used across 10 studies
(see Multimedia Appendix 2 for the main results of the studies
that conducted economic evaluation of home telemonitoring).
The most popular technique was cost-effectiveness analysis
used in three studies with different fields of application. These
three studies were able to show outcome improvements and
cost savings. Table 7 presents the scalability assessment studies
concerning the setting and workforce, infrastructure, and
sustainability domains for implementation planning
Table 6. Quantitative research studies focusing on data collection using document screening and published databases for scalability assessment
considering the costs and benefits domain for scale-up (research focus: economic evaluation).







[36]1Value of information analysis
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Table 7. Studies on scalability assessment concerning the setting and workforce, infrastructure, and sustainability domains for implementation planning.
ReferenceStudies, nData analysis tech-
nique
Data collection techniqueDomain and research focus and type
Setting and workforce
Setting and workforce assessment











Opportunity and challenge assessment





All the 13 articles assessed scalability based on the results
achieved in the respective studies. Table 8 summarizes the
assessments obtained through narrative analysis. On the one
hand, two studies provided positive assessments regarding the
potential to scale-up the intervention. On the other hand, eight
studies highlighted the need for cost-effectiveness or cost-benefit
analysis before proceeding to scale-up the intervention.
Table 8. Scalability assessment based on the authors’ conclusions in each study.
ReferenceStudies, NScalability assessment
[27]1Not able to be expanded
[34]1Able to be expanded, but the diffusion and sustainability will depend on a supportive policy en-
vironment
[28,36,38,39]3Able to be expanded but requires cost-benefit analysis for reimbursement planning
[29,30,35]3Able to be expanded but requires cost-effectiveness analysis
[32,33]2Able to be expanded but requires some technical changes, cost-benefit analysis for reimbursement
planning, and solutions for regulatory issues
[31,37]2Able to be expanded under real-world conditions
Discussion
Principal Results
Despite the rapid growth of telemedicine applications in the last
few years, particularly after the emergence of COVID-19,
scientific studies assessing the scalability of these health
interventions are scarce [19].
In this review, all the eligible studies are from developed
countries, particularly the United States and Canada. The
absence of such studies in developing countries could be owing
to the lack of specialized human resources, information and
communications technology (ICT) infrastructure, and equipment
[46]. Besides, the significant difference found between North
America and Europe might be related to the requirement of
evidence to justify private payer reimbursement for health care
interventions [47] or the investment in developing strategies to
encourage telemedicine adoption [48]. Nevertheless, this review
has not identified studies from countries that invested
significantly in telehealth solutions, such as the United Kingdom
or Australia [46]. The justification for this might be the frequent
research focus of health interventions on clinical effectiveness
[11], instead of assessing their scale-up potential. More than
half of the studies were published between 2018 and 2020. Thus,
this research area is receiving more attention from the scientific
community as a logical next step after demonstrating robust
evidence regarding the effectiveness and technological maturity
of such interventions.
The use of one of the most recent scalability assessment
frameworks [18] granted the opportunity to compare the
strategies used to assess the scale-up potentials of interventions
in each study. This advantage of this framework is that it allows
the analysis of different domains considering the stage of the
transference process of an intervention from a research setting
into the practical implementation stage.
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This review suggests an agreement in some analyzed domains,
such as problems, interventions, effectiveness, costs, and
benefits, to support the decision to scale-up interventions.
However, this is not the case for the methods and instruments
used. For example, although cost-effectiveness was the most
common approach across the 13 studies, researchers used 7
different cost analysis methods. Moreover, to demonstrate
effectiveness, studies provided evidence of different outcomes,
such as clinical, humanistic, and utilization outcomes. This
inconsistency leads to different scalability assessments and does
not enable comparing interventions with home telemonitoring
technologies.
There is a recognized methodological gap in understanding
other relevant domains such as the sociopolitical context, setting,
workforce, and implementation infrastructure to provide the
home telemonitoring intervention to the target population. A
common framework will allow determining if interventions
demonstrated as effective are appropriate and feasible in other
settings [18,49].
Lastly, another relevant result obtained from this systematic
review was that researchers assigned different weights to the
analyzed domains when concluding the intervention scalability.
On the one hand, 12 studies concluded their ability to scale- up
based on the costs and outcomes of the interventions, although
they had analyzed other domains. On the other hand, one study
restrained the decision to scale-up the intervention based on the
policy environment. Future research should address the influence
that each domain has on the final decision to scale-up the
interventions with sound and transparent methods, avoiding
mistakes reported in the literature [50].
Limitations
This relevant limitation of this review might be associated with
the low maturity of this research area, despite its recent growth.
Additionally, one database filter concerned peer-reviewed
journals, which influenced the rejection of studies with no
statistical significance but could have been relevant in this
review with respect to the domains and methods used when
assessing scalability. This review only considered studies
published in English, which might have influenced the number
of eligible studies. Moreover, the authors did not conduct a
meta-analysis owing to the limited number of studies on this
subject. Finally, the domains used to analyze the scalability
assessment strategies were predefined, thus limiting the
spectrum of domains studied.
Conclusions
Studies on home telemonitoring interventions integrated into
follow-up care have already proved their efficacy. Although
some studies focused on including domains such as
effectiveness, costs, and benefits, these are not enough to assess
the potential of scaling up these interventions. As technology
progresses and the need for providing care to more people in
their homes increases, it is extremely important to conduct more
studies on scalability assessment considering domains such as
workforce and infrastructure characteristics and the strategic
context. Future research should establish rigorous study designs
and scientific methods to assess scalability based on the results
of this systematic review. Further understanding of the usage
of health services and medium- and long-term sustainability of
interventions would yield more robust evidence to support their
future integration into mainstream care delivery systems. This
research area, although still emerging, will advance knowledge
on the factors that influence the successful scale-up of
interventions.
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Glossary of research methods and scalability assessment domains used to systematically review the eligible studies in this work.
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